These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28939575)

  • 1. Urine cytology screening of French workers exposed to occupational urinary tract carcinogens: a prospective cohort study over a 20-year period.
    Dutheil F; Rouanet L; Mulliez A; Naughton G; Fontana L; Druet-Cabanac M; Moustafa F; Chamoux A
    BMJ Open; 2017 Sep; 7(9):e016238. PubMed ID: 28939575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines.
    Shinka T; Miyai M; Sawada Y; Inagaki T; Okawa T
    Int J Urol; 1995 Sep; 2(4):243-8. PubMed ID: 8564742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of occupational uroepithelial cancer].
    Hamasaki T; Aramaki K; Hida T; Inatomi H; Fujimoto N; Okamura T; Ozu K; Sugita A
    J UOEH; 1996 Dec; 18(4):247-59. PubMed ID: 8981648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France.
    Marant Micallef C; Paul A; Charvat H; Vignat J; Houot M; Pilorget C; Straif K; El Yamani M; Soerjomataram I
    J Expo Sci Environ Epidemiol; 2021 Jul; 31(4):769-776. PubMed ID: 33144638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer occurrence among dyestuff workers exposed to aromatic amines. A long term follow-up study.
    Naito S; Tanaka K; Koga H; Kotoh S; Hirohata T; Kumazawa J
    Cancer; 1995 Oct; 76(8):1445-52. PubMed ID: 8620422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
    BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
    Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How accurate is urine cytology?
    Curling M; Broome G; Hendry WF
    J R Soc Med; 1986 Jun; 79(6):336-8. PubMed ID: 3723535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
    Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
    Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
    Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
    Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
    Straccia P; Bizzarro T; Fadda G; Pierconti F
    Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of patients with occupational urothelial tumors].
    Matsuoka K; Eto K; Yoshitake N
    Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1118-24. PubMed ID: 1895626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
    Clin B; ; Pairon JC
    BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
    Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
    Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational urothelial tumours: a regional case-control study.
    Sorahan T; Hamilton L; Wallace DM; Bathers S; Gardiner K; Harrington JM
    Br J Urol; 1998 Jul; 82(1):25-32. PubMed ID: 9698659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.